nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—SLCO1B1—breast cancer	0.141	0.375	CbGaD
Rosuvastatin—ABCC1—breast cancer	0.117	0.309	CbGaD
Rosuvastatin—ABCG2—breast cancer	0.0615	0.163	CbGaD
Rosuvastatin—CYP3A4—breast cancer	0.0308	0.0816	CbGaD
Rosuvastatin—ABCC1—Idarubicin—breast cancer	0.0282	0.0677	CbGbCtD
Rosuvastatin—ALB—breast cancer	0.0268	0.0711	CbGaD
Rosuvastatin—SLCO1A2—Chlorambucil—breast cancer	0.0252	0.0604	CbGbCtD
Rosuvastatin—ABCB11—Tamoxifen—breast cancer	0.0175	0.042	CbGbCtD
Rosuvastatin—SLCO1B3—Paclitaxel—breast cancer	0.014	0.0336	CbGbCtD
Rosuvastatin—ABCB11—Paclitaxel—breast cancer	0.0136	0.0327	CbGbCtD
Rosuvastatin—ABCC1—Mitoxantrone—breast cancer	0.0121	0.0291	CbGbCtD
Rosuvastatin—ABCB11—Vinblastine—breast cancer	0.0119	0.0287	CbGbCtD
Rosuvastatin—ABCC4—Fluorouracil—breast cancer	0.0114	0.0274	CbGbCtD
Rosuvastatin—SLCO1B3—Docetaxel—breast cancer	0.0101	0.0243	CbGbCtD
Rosuvastatin—ABCC1—Epirubicin—breast cancer	0.00981	0.0236	CbGbCtD
Rosuvastatin—ABCC1—Paclitaxel—breast cancer	0.00967	0.0232	CbGbCtD
Rosuvastatin—ABCC1—Irinotecan—breast cancer	0.00954	0.0229	CbGbCtD
Rosuvastatin—CYP2C9—Anastrozole—breast cancer	0.00925	0.0222	CbGbCtD
Rosuvastatin—CYP3A5—Lapatinib—breast cancer	0.0092	0.0221	CbGbCtD
Rosuvastatin—ABCC1—Vinblastine—breast cancer	0.00849	0.0204	CbGbCtD
Rosuvastatin—ABCG2—Tamoxifen—breast cancer	0.00832	0.02	CbGbCtD
Rosuvastatin—ABCG2—Mitoxantrone—breast cancer	0.00811	0.0195	CbGbCtD
Rosuvastatin—SLCO1B1—Irinotecan—breast cancer	0.00804	0.0193	CbGbCtD
Rosuvastatin—CYP2C19—Lapatinib—breast cancer	0.00742	0.0178	CbGbCtD
Rosuvastatin—ABCB11—Doxorubicin—breast cancer	0.00734	0.0176	CbGbCtD
Rosuvastatin—SLCO1B3—Methotrexate—breast cancer	0.00731	0.0175	CbGbCtD
Rosuvastatin—CYP3A4—Exemestane—breast cancer	0.0071	0.017	CbGbCtD
Rosuvastatin—CYP2C9—Idarubicin—breast cancer	0.00701	0.0168	CbGbCtD
Rosuvastatin—ABCC1—Docetaxel—breast cancer	0.00699	0.0168	CbGbCtD
Rosuvastatin—ABCG2—Paclitaxel—breast cancer	0.00647	0.0155	CbGbCtD
Rosuvastatin—ABCG2—Irinotecan—breast cancer	0.00639	0.0153	CbGbCtD
Rosuvastatin—ABCC4—Methotrexate—breast cancer	0.00629	0.0151	CbGbCtD
Rosuvastatin—ABCG2—Fluorouracil—breast cancer	0.00613	0.0147	CbGbCtD
Rosuvastatin—ABCG2—Carboplatin—breast cancer	0.00609	0.0146	CbGbCtD
Rosuvastatin—CYP3A4—Letrozole—breast cancer	0.00603	0.0145	CbGbCtD
Rosuvastatin—CYP3A4—Anastrozole—breast cancer	0.00538	0.0129	CbGbCtD
Rosuvastatin—ABCC1—Doxorubicin—breast cancer	0.00521	0.0125	CbGbCtD
Rosuvastatin—ABCC1—Methotrexate—breast cancer	0.00505	0.0121	CbGbCtD
Rosuvastatin—CYP3A4—Toremifene—breast cancer	0.00492	0.0118	CbGbCtD
Rosuvastatin—ABCG2—Docetaxel—breast cancer	0.00468	0.0112	CbGbCtD
Rosuvastatin—CYP3A5—Tamoxifen—breast cancer	0.00461	0.0111	CbGbCtD
Rosuvastatin—CYP3A4—Fulvestrant—breast cancer	0.00457	0.011	CbGbCtD
Rosuvastatin—SLCO1A2—Methotrexate—breast cancer	0.00451	0.0108	CbGbCtD
Rosuvastatin—ALB—Irinotecan—breast cancer	0.0044	0.0106	CbGbCtD
Rosuvastatin—SLCO1B1—Methotrexate—breast cancer	0.00425	0.0102	CbGbCtD
Rosuvastatin—ALB—Fluorouracil—breast cancer	0.00423	0.0101	CbGbCtD
Rosuvastatin—CYP3A4—Thiotepa—breast cancer	0.00408	0.00979	CbGbCtD
Rosuvastatin—CYP2C9—Capecitabine—breast cancer	0.00384	0.00922	CbGbCtD
Rosuvastatin—CYP3A4—Ixabepilone—breast cancer	0.00373	0.00895	CbGbCtD
Rosuvastatin—CYP2C19—Tamoxifen—breast cancer	0.00372	0.00892	CbGbCtD
Rosuvastatin—CYP3A4—Lapatinib—breast cancer	0.00359	0.00862	CbGbCtD
Rosuvastatin—CYP3A5—Paclitaxel—breast cancer	0.00359	0.00861	CbGbCtD
Rosuvastatin—CYP3A5—Irinotecan—breast cancer	0.00354	0.0085	CbGbCtD
Rosuvastatin—ABCG2—Doxorubicin—breast cancer	0.00349	0.00838	CbGbCtD
Rosuvastatin—ABCG2—Methotrexate—breast cancer	0.00338	0.00812	CbGbCtD
Rosuvastatin—CYP2C9—Tamoxifen—breast cancer	0.00309	0.00742	CbGbCtD
Rosuvastatin—CYP3A4—Raloxifene—breast cancer	0.00272	0.00653	CbGbCtD
Rosuvastatin—CYP3A5—Docetaxel—breast cancer	0.00259	0.00623	CbGbCtD
Rosuvastatin—CYP2C9—Paclitaxel—breast cancer	0.00241	0.00578	CbGbCtD
Rosuvastatin—ALB—Methotrexate—breast cancer	0.00233	0.00559	CbGbCtD
Rosuvastatin—CYP2C9—Fluorouracil—breast cancer	0.00228	0.00547	CbGbCtD
Rosuvastatin—CYP3A4—Vinorelbine—breast cancer	0.00199	0.00478	CbGbCtD
Rosuvastatin—CYP3A4—Tamoxifen—breast cancer	0.0018	0.00431	CbGbCtD
Rosuvastatin—CYP3A4—Mitoxantrone—breast cancer	0.00175	0.00421	CbGbCtD
Rosuvastatin—CYP3A4—Paclitaxel—breast cancer	0.0014	0.00336	CbGbCtD
Rosuvastatin—CYP3A4—Irinotecan—breast cancer	0.00138	0.00331	CbGbCtD
Rosuvastatin—CYP3A4—Vinblastine—breast cancer	0.00123	0.00295	CbGbCtD
Rosuvastatin—CYP3A4—Docetaxel—breast cancer	0.00101	0.00243	CbGbCtD
Rosuvastatin—SLCO1B1—mammary gland—breast cancer	0.000836	0.0382	CbGeAlD
Rosuvastatin—Pitavastatin—SLCO1B1—breast cancer	0.000811	0.287	CrCbGaD
Rosuvastatin—CYP3A4—Doxorubicin—breast cancer	0.000754	0.00181	CbGbCtD
Rosuvastatin—Fluvastatin—SLCO1B1—breast cancer	0.00075	0.266	CrCbGaD
Rosuvastatin—SLCO2B1—mammary gland—breast cancer	0.00074	0.0338	CbGeAlD
Rosuvastatin—HMGCR—nipple—breast cancer	0.000722	0.033	CbGeAlD
Rosuvastatin—ALB—mammary gland—breast cancer	0.000677	0.0309	CbGeAlD
Rosuvastatin—SLCO1B3—pituitary gland—breast cancer	0.000654	0.0299	CbGeAlD
Rosuvastatin—SLC7A11—adipose tissue—breast cancer	0.000632	0.0289	CbGeAlD
Rosuvastatin—SLC7A11—Dexamethasone—Fluoxymesterone—breast cancer	0.000599	0.5	CbGdCrCtD
Rosuvastatin—SLC7A11—Betamethasone—Fluoxymesterone—breast cancer	0.000599	0.5	CbGdCrCtD
Rosuvastatin—SLC7A11—female reproductive system—breast cancer	0.000581	0.0266	CbGeAlD
Rosuvastatin—SLC7A11—female gonad—breast cancer	0.000529	0.0242	CbGeAlD
Rosuvastatin—SLCO1B3—endocrine gland—breast cancer	0.000506	0.0231	CbGeAlD
Rosuvastatin—SLC7A11—endocrine gland—breast cancer	0.000492	0.0225	CbGeAlD
Rosuvastatin—HMGCR—epithelium—breast cancer	0.000486	0.0222	CbGeAlD
Rosuvastatin—HMGCR—skin of body—breast cancer	0.000462	0.0211	CbGeAlD
Rosuvastatin—ABCC1—nipple—breast cancer	0.000462	0.0211	CbGeAlD
Rosuvastatin—ABCB11—endocrine gland—breast cancer	0.000437	0.02	CbGeAlD
Rosuvastatin—HMGCR—endometrium—breast cancer	0.000436	0.0199	CbGeAlD
Rosuvastatin—CYP2C9—mammary gland—breast cancer	0.000422	0.0193	CbGeAlD
Rosuvastatin—HMGCR—uterus—breast cancer	0.000402	0.0184	CbGeAlD
Rosuvastatin—HMGCR—pituitary gland—breast cancer	0.000395	0.018	CbGeAlD
Rosuvastatin—HMGCR—adipose tissue—breast cancer	0.000393	0.018	CbGeAlD
Rosuvastatin—HMGCR—female reproductive system—breast cancer	0.000361	0.0165	CbGeAlD
Rosuvastatin—Pitavastatin—ABCG2—breast cancer	0.000353	0.125	CrCbGaD
Rosuvastatin—HMGCR—adrenal gland—breast cancer	0.000352	0.0161	CbGeAlD
Rosuvastatin—SLCO1B1—female reproductive system—breast cancer	0.000346	0.0158	CbGeAlD
Rosuvastatin—HMGCR—bone marrow—breast cancer	0.000341	0.0156	CbGeAlD
Rosuvastatin—SLCO2B1—uterus—breast cancer	0.00034	0.0156	CbGeAlD
Rosuvastatin—SLCO2B1—adipose tissue—breast cancer	0.000333	0.0152	CbGeAlD
Rosuvastatin—HMGCR—female gonad—breast cancer	0.000329	0.015	CbGeAlD
Rosuvastatin—SLCO2B1—female reproductive system—breast cancer	0.000306	0.014	CbGeAlD
Rosuvastatin—HMGCR—endocrine gland—breast cancer	0.000306	0.014	CbGeAlD
Rosuvastatin—ABCC4—uterus—breast cancer	0.000301	0.0138	CbGeAlD
Rosuvastatin—SLCO2B1—adrenal gland—breast cancer	0.000299	0.0136	CbGeAlD
Rosuvastatin—ABCC4—adipose tissue—breast cancer	0.000295	0.0135	CbGeAlD
Rosuvastatin—SLCO1B1—endocrine gland—breast cancer	0.000293	0.0134	CbGeAlD
Rosuvastatin—ABCC1—endometrium—breast cancer	0.000279	0.0127	CbGeAlD
Rosuvastatin—SLCO2B1—female gonad—breast cancer	0.000278	0.0127	CbGeAlD
Rosuvastatin—ALB—adrenal gland—breast cancer	0.000273	0.0125	CbGeAlD
Rosuvastatin—ABCC4—female reproductive system—breast cancer	0.000271	0.0124	CbGeAlD
Rosuvastatin—ABCC4—adrenal gland—breast cancer	0.000264	0.0121	CbGeAlD
Rosuvastatin—SLCO2B1—endocrine gland—breast cancer	0.000259	0.0118	CbGeAlD
Rosuvastatin—ABCC1—uterus—breast cancer	0.000257	0.0117	CbGeAlD
Rosuvastatin—Fluvastatin—CYP1A1—breast cancer	0.000256	0.0906	CrCbGaD
Rosuvastatin—ABCC4—bone marrow—breast cancer	0.000256	0.0117	CbGeAlD
Rosuvastatin—ABCC1—pituitary gland—breast cancer	0.000252	0.0115	CbGeAlD
Rosuvastatin—ABCC1—adipose tissue—breast cancer	0.000251	0.0115	CbGeAlD
Rosuvastatin—ABCC4—female gonad—breast cancer	0.000247	0.0113	CbGeAlD
Rosuvastatin—SLCO1A2—endocrine gland—breast cancer	0.000238	0.0109	CbGeAlD
Rosuvastatin—ABCG2—endometrium—breast cancer	0.000231	0.0106	CbGeAlD
Rosuvastatin—ABCC4—endocrine gland—breast cancer	0.000229	0.0105	CbGeAlD
Rosuvastatin—ABCC1—adrenal gland—breast cancer	0.000225	0.0103	CbGeAlD
Rosuvastatin—ABCG2—uterus—breast cancer	0.000213	0.00973	CbGeAlD
Rosuvastatin—HMGCR—lymph node—breast cancer	0.000211	0.00966	CbGeAlD
Rosuvastatin—ABCC1—female gonad—breast cancer	0.00021	0.00961	CbGeAlD
Rosuvastatin—ABCG2—pituitary gland—breast cancer	0.000209	0.00955	CbGeAlD
Rosuvastatin—ABCG2—adipose tissue—breast cancer	0.000208	0.00951	CbGeAlD
Rosuvastatin—CYP3A5—adipose tissue—breast cancer	0.000193	0.00883	CbGeAlD
Rosuvastatin—CYP2C19—endocrine gland—breast cancer	0.000191	0.00872	CbGeAlD
Rosuvastatin—Fluvastatin—CYP2D6—breast cancer	0.00019	0.0674	CrCbGaD
Rosuvastatin—ABCG2—adrenal gland—breast cancer	0.000187	0.00853	CbGeAlD
Rosuvastatin—ABCG2—bone marrow—breast cancer	0.000181	0.00825	CbGeAlD
Rosuvastatin—SLCO2B1—lymph node—breast cancer	0.000179	0.00818	CbGeAlD
Rosuvastatin—CYP2C9—female reproductive system—breast cancer	0.000175	0.00799	CbGeAlD
Rosuvastatin—ABCG2—female gonad—breast cancer	0.000174	0.00796	CbGeAlD
Rosuvastatin—ALB—lymph node—breast cancer	0.000164	0.00748	CbGeAlD
Rosuvastatin—Fluvastatin—CYP3A4—breast cancer	0.000163	0.0578	CrCbGaD
Rosuvastatin—CYP3A5—female gonad—breast cancer	0.000162	0.00738	CbGeAlD
Rosuvastatin—ABCC4—lymph node—breast cancer	0.000159	0.00725	CbGeAlD
Rosuvastatin—Pitavastatin—ALB—breast cancer	0.000154	0.0545	CrCbGaD
Rosuvastatin—CYP3A5—endocrine gland—breast cancer	0.00015	0.00687	CbGeAlD
Rosuvastatin—CYP2C9—endocrine gland—breast cancer	0.000148	0.00676	CbGeAlD
Rosuvastatin—Pitavastatin—ABCB1—breast cancer	0.000147	0.052	CrCbGaD
Rosuvastatin—ABCC1—lymph node—breast cancer	0.000135	0.00618	CbGeAlD
Rosuvastatin—CYP3A4—female reproductive system—breast cancer	0.000133	0.00609	CbGeAlD
Rosuvastatin—CYP3A4—endocrine gland—breast cancer	0.000113	0.00515	CbGeAlD
Rosuvastatin—ABCG2—lymph node—breast cancer	0.000112	0.00511	CbGeAlD
Rosuvastatin—Pain—Gemcitabine—breast cancer	5.73e-05	0.000566	CcSEcCtD
Rosuvastatin—Constipation—Gemcitabine—breast cancer	5.73e-05	0.000566	CcSEcCtD
Rosuvastatin—Asthenia—Thiotepa—breast cancer	5.71e-05	0.000565	CcSEcCtD
Rosuvastatin—Diarrhoea—Vinorelbine—breast cancer	5.7e-05	0.000564	CcSEcCtD
Rosuvastatin—Mental disorder—Capecitabine—breast cancer	5.67e-05	0.000561	CcSEcCtD
Rosuvastatin—Nausea—Melphalan—breast cancer	5.67e-05	0.00056	CcSEcCtD
Rosuvastatin—Feeling abnormal—Mitoxantrone—breast cancer	5.66e-05	0.00056	CcSEcCtD
Rosuvastatin—Feeling abnormal—Irinotecan—breast cancer	5.66e-05	0.00056	CcSEcCtD
Rosuvastatin—Confusional state—Paclitaxel—breast cancer	5.65e-05	0.000559	CcSEcCtD
Rosuvastatin—Influenza—Epirubicin—breast cancer	5.64e-05	0.000557	CcSEcCtD
Rosuvastatin—Pruritus—Thiotepa—breast cancer	5.63e-05	0.000557	CcSEcCtD
Rosuvastatin—Pain—Fluorouracil—breast cancer	5.63e-05	0.000557	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Irinotecan—breast cancer	5.62e-05	0.000556	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Mitoxantrone—breast cancer	5.62e-05	0.000556	CcSEcCtD
Rosuvastatin—Infection—Paclitaxel—breast cancer	5.57e-05	0.000551	CcSEcCtD
Rosuvastatin—Flatulence—Capecitabine—breast cancer	5.55e-05	0.000549	CcSEcCtD
Rosuvastatin—Nausea—Goserelin—breast cancer	5.53e-05	0.000546	CcSEcCtD
Rosuvastatin—Pancreatitis—Epirubicin—breast cancer	5.52e-05	0.000546	CcSEcCtD
Rosuvastatin—Feeling abnormal—Gemcitabine—breast cancer	5.52e-05	0.000546	CcSEcCtD
Rosuvastatin—Dizziness—Vinorelbine—breast cancer	5.51e-05	0.000545	CcSEcCtD
Rosuvastatin—Nervous system disorder—Paclitaxel—breast cancer	5.5e-05	0.000544	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Paclitaxel—breast cancer	5.49e-05	0.000543	CcSEcCtD
Rosuvastatin—Urticaria—Mitoxantrone—breast cancer	5.46e-05	0.00054	CcSEcCtD
Rosuvastatin—Breast disorder—Doxorubicin—breast cancer	5.45e-05	0.000539	CcSEcCtD
Rosuvastatin—Diarrhoea—Thiotepa—breast cancer	5.45e-05	0.000538	CcSEcCtD
Rosuvastatin—Abdominal pain—Irinotecan—breast cancer	5.43e-05	0.000537	CcSEcCtD
Rosuvastatin—Abdominal pain—Mitoxantrone—breast cancer	5.43e-05	0.000537	CcSEcCtD
Rosuvastatin—Feeling abnormal—Fluorouracil—breast cancer	5.42e-05	0.000536	CcSEcCtD
Rosuvastatin—Bronchitis—Epirubicin—breast cancer	5.42e-05	0.000536	CcSEcCtD
Rosuvastatin—Depression—Methotrexate—breast cancer	5.35e-05	0.000529	CcSEcCtD
Rosuvastatin—Muscular weakness—Doxorubicin—breast cancer	5.32e-05	0.000526	CcSEcCtD
Rosuvastatin—Dizziness—Thiotepa—breast cancer	5.26e-05	0.00052	CcSEcCtD
Rosuvastatin—Rash—Vinorelbine—breast cancer	5.25e-05	0.00052	CcSEcCtD
Rosuvastatin—Dermatitis—Vinorelbine—breast cancer	5.25e-05	0.000519	CcSEcCtD
Rosuvastatin—Urticaria—Fluorouracil—breast cancer	5.23e-05	0.000517	CcSEcCtD
Rosuvastatin—Headache—Vinorelbine—breast cancer	5.22e-05	0.000516	CcSEcCtD
Rosuvastatin—Influenza—Doxorubicin—breast cancer	5.21e-05	0.000516	CcSEcCtD
Rosuvastatin—Haematuria—Methotrexate—breast cancer	5.12e-05	0.000506	CcSEcCtD
Rosuvastatin—Pancreatitis—Doxorubicin—breast cancer	5.11e-05	0.000505	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Paclitaxel—breast cancer	5.11e-05	0.000505	CcSEcCtD
Rosuvastatin—Cough—Docetaxel—breast cancer	5.08e-05	0.000502	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Methotrexate—breast cancer	5.08e-05	0.000502	CcSEcCtD
Rosuvastatin—Insomnia—Paclitaxel—breast cancer	5.07e-05	0.000501	CcSEcCtD
Rosuvastatin—Hypersensitivity—Irinotecan—breast cancer	5.06e-05	0.000501	CcSEcCtD
Rosuvastatin—Hypersensitivity—Mitoxantrone—breast cancer	5.06e-05	0.000501	CcSEcCtD
Rosuvastatin—Paraesthesia—Paclitaxel—breast cancer	5.03e-05	0.000498	CcSEcCtD
Rosuvastatin—Rash—Thiotepa—breast cancer	5.02e-05	0.000496	CcSEcCtD
Rosuvastatin—Bronchitis—Doxorubicin—breast cancer	5.01e-05	0.000496	CcSEcCtD
Rosuvastatin—Dermatitis—Thiotepa—breast cancer	5.01e-05	0.000496	CcSEcCtD
Rosuvastatin—Headache—Thiotepa—breast cancer	4.99e-05	0.000493	CcSEcCtD
Rosuvastatin—Arthralgia—Docetaxel—breast cancer	4.96e-05	0.00049	CcSEcCtD
Rosuvastatin—Myalgia—Docetaxel—breast cancer	4.96e-05	0.00049	CcSEcCtD
Rosuvastatin—Nausea—Vinorelbine—breast cancer	4.95e-05	0.000489	CcSEcCtD
Rosuvastatin—Dyspepsia—Paclitaxel—breast cancer	4.93e-05	0.000488	CcSEcCtD
Rosuvastatin—Asthenia—Mitoxantrone—breast cancer	4.93e-05	0.000488	CcSEcCtD
Rosuvastatin—Asthenia—Irinotecan—breast cancer	4.93e-05	0.000488	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Epirubicin—breast cancer	4.93e-05	0.000487	CcSEcCtD
Rosuvastatin—Cough—Capecitabine—breast cancer	4.92e-05	0.000486	CcSEcCtD
Rosuvastatin—Jaundice—Epirubicin—breast cancer	4.9e-05	0.000484	CcSEcCtD
Rosuvastatin—Urinary tract infection—Epirubicin—breast cancer	4.88e-05	0.000483	CcSEcCtD
Rosuvastatin—Hypersensitivity—Fluorouracil—breast cancer	4.85e-05	0.00048	CcSEcCtD
Rosuvastatin—Hepatitis—Methotrexate—breast cancer	4.82e-05	0.000477	CcSEcCtD
Rosuvastatin—Asthenia—Gemcitabine—breast cancer	4.8e-05	0.000475	CcSEcCtD
Rosuvastatin—Arthralgia—Capecitabine—breast cancer	4.8e-05	0.000474	CcSEcCtD
Rosuvastatin—Myalgia—Capecitabine—breast cancer	4.8e-05	0.000474	CcSEcCtD
Rosuvastatin—Constipation—Paclitaxel—breast cancer	4.79e-05	0.000474	CcSEcCtD
Rosuvastatin—Pain—Paclitaxel—breast cancer	4.79e-05	0.000474	CcSEcCtD
Rosuvastatin—Haematuria—Epirubicin—breast cancer	4.79e-05	0.000474	CcSEcCtD
Rosuvastatin—Confusional state—Docetaxel—breast cancer	4.79e-05	0.000474	CcSEcCtD
Rosuvastatin—Pharyngitis—Methotrexate—breast cancer	4.78e-05	0.000473	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Epirubicin—breast cancer	4.75e-05	0.00047	CcSEcCtD
Rosuvastatin—Pruritus—Gemcitabine—breast cancer	4.74e-05	0.000468	CcSEcCtD
Rosuvastatin—Nausea—Thiotepa—breast cancer	4.73e-05	0.000467	CcSEcCtD
Rosuvastatin—Infection—Docetaxel—breast cancer	4.72e-05	0.000467	CcSEcCtD
Rosuvastatin—Sinusitis—Epirubicin—breast cancer	4.71e-05	0.000466	CcSEcCtD
Rosuvastatin—Diarrhoea—Mitoxantrone—breast cancer	4.7e-05	0.000465	CcSEcCtD
Rosuvastatin—Diarrhoea—Irinotecan—breast cancer	4.7e-05	0.000465	CcSEcCtD
Rosuvastatin—Nervous system disorder—Docetaxel—breast cancer	4.66e-05	0.000461	CcSEcCtD
Rosuvastatin—Pruritus—Fluorouracil—breast cancer	4.66e-05	0.00046	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Docetaxel—breast cancer	4.65e-05	0.00046	CcSEcCtD
Rosuvastatin—Confusional state—Capecitabine—breast cancer	4.64e-05	0.000459	CcSEcCtD
Rosuvastatin—Feeling abnormal—Paclitaxel—breast cancer	4.62e-05	0.000457	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Paclitaxel—breast cancer	4.58e-05	0.000453	CcSEcCtD
Rosuvastatin—Diarrhoea—Gemcitabine—breast cancer	4.58e-05	0.000453	CcSEcCtD
Rosuvastatin—Infection—Capecitabine—breast cancer	4.57e-05	0.000452	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Doxorubicin—breast cancer	4.56e-05	0.000451	CcSEcCtD
Rosuvastatin—Dizziness—Irinotecan—breast cancer	4.54e-05	0.000449	CcSEcCtD
Rosuvastatin—Jaundice—Doxorubicin—breast cancer	4.53e-05	0.000448	CcSEcCtD
Rosuvastatin—Rhinitis—Epirubicin—breast cancer	4.52e-05	0.000447	CcSEcCtD
Rosuvastatin—Urinary tract infection—Doxorubicin—breast cancer	4.52e-05	0.000447	CcSEcCtD
Rosuvastatin—Nervous system disorder—Capecitabine—breast cancer	4.51e-05	0.000446	CcSEcCtD
Rosuvastatin—Hepatitis—Epirubicin—breast cancer	4.51e-05	0.000446	CcSEcCtD
Rosuvastatin—Diarrhoea—Fluorouracil—breast cancer	4.5e-05	0.000445	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Capecitabine—breast cancer	4.5e-05	0.000445	CcSEcCtD
Rosuvastatin—Pharyngitis—Epirubicin—breast cancer	4.48e-05	0.000443	CcSEcCtD
Rosuvastatin—Urticaria—Paclitaxel—breast cancer	4.45e-05	0.00044	CcSEcCtD
Rosuvastatin—Haematuria—Doxorubicin—breast cancer	4.43e-05	0.000438	CcSEcCtD
Rosuvastatin—Abdominal pain—Paclitaxel—breast cancer	4.43e-05	0.000438	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Doxorubicin—breast cancer	4.4e-05	0.000435	CcSEcCtD
Rosuvastatin—Sinusitis—Doxorubicin—breast cancer	4.36e-05	0.000431	CcSEcCtD
Rosuvastatin—Dizziness—Fluorouracil—breast cancer	4.35e-05	0.00043	CcSEcCtD
Rosuvastatin—Rash—Irinotecan—breast cancer	4.33e-05	0.000428	CcSEcCtD
Rosuvastatin—Rash—Mitoxantrone—breast cancer	4.33e-05	0.000428	CcSEcCtD
Rosuvastatin—Dermatitis—Mitoxantrone—breast cancer	4.33e-05	0.000428	CcSEcCtD
Rosuvastatin—Dermatitis—Irinotecan—breast cancer	4.33e-05	0.000428	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Docetaxel—breast cancer	4.33e-05	0.000428	CcSEcCtD
Rosuvastatin—Headache—Irinotecan—breast cancer	4.31e-05	0.000426	CcSEcCtD
Rosuvastatin—Headache—Mitoxantrone—breast cancer	4.31e-05	0.000426	CcSEcCtD
Rosuvastatin—Insomnia—Docetaxel—breast cancer	4.3e-05	0.000425	CcSEcCtD
Rosuvastatin—Paraesthesia—Docetaxel—breast cancer	4.27e-05	0.000422	CcSEcCtD
Rosuvastatin—Mental disorder—Methotrexate—breast cancer	4.22e-05	0.000418	CcSEcCtD
Rosuvastatin—Rash—Gemcitabine—breast cancer	4.22e-05	0.000417	CcSEcCtD
Rosuvastatin—Dermatitis—Gemcitabine—breast cancer	4.22e-05	0.000417	CcSEcCtD
Rosuvastatin—Headache—Gemcitabine—breast cancer	4.19e-05	0.000415	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Capecitabine—breast cancer	4.19e-05	0.000414	CcSEcCtD
Rosuvastatin—Rhinitis—Doxorubicin—breast cancer	4.18e-05	0.000414	CcSEcCtD
Rosuvastatin—Dyspepsia—Docetaxel—breast cancer	4.18e-05	0.000414	CcSEcCtD
Rosuvastatin—Hepatitis—Doxorubicin—breast cancer	4.17e-05	0.000413	CcSEcCtD
Rosuvastatin—Insomnia—Capecitabine—breast cancer	4.16e-05	0.000411	CcSEcCtD
Rosuvastatin—Rash—Fluorouracil—breast cancer	4.15e-05	0.00041	CcSEcCtD
Rosuvastatin—Dermatitis—Fluorouracil—breast cancer	4.15e-05	0.00041	CcSEcCtD
Rosuvastatin—Pharyngitis—Doxorubicin—breast cancer	4.14e-05	0.00041	CcSEcCtD
Rosuvastatin—Paraesthesia—Capecitabine—breast cancer	4.13e-05	0.000408	CcSEcCtD
Rosuvastatin—Hypersensitivity—Paclitaxel—breast cancer	4.13e-05	0.000408	CcSEcCtD
Rosuvastatin—Headache—Fluorouracil—breast cancer	4.12e-05	0.000408	CcSEcCtD
Rosuvastatin—Nausea—Mitoxantrone—breast cancer	4.08e-05	0.000404	CcSEcCtD
Rosuvastatin—Nausea—Irinotecan—breast cancer	4.08e-05	0.000404	CcSEcCtD
Rosuvastatin—Pain—Docetaxel—breast cancer	4.06e-05	0.000402	CcSEcCtD
Rosuvastatin—Constipation—Docetaxel—breast cancer	4.06e-05	0.000402	CcSEcCtD
Rosuvastatin—Dyspepsia—Capecitabine—breast cancer	4.05e-05	0.0004	CcSEcCtD
Rosuvastatin—Arrhythmia—Epirubicin—breast cancer	4.03e-05	0.000398	CcSEcCtD
Rosuvastatin—Asthenia—Paclitaxel—breast cancer	4.02e-05	0.000398	CcSEcCtD
Rosuvastatin—Nausea—Gemcitabine—breast cancer	3.98e-05	0.000393	CcSEcCtD
Rosuvastatin—Pruritus—Paclitaxel—breast cancer	3.97e-05	0.000392	CcSEcCtD
Rosuvastatin—Mental disorder—Epirubicin—breast cancer	3.95e-05	0.000391	CcSEcCtD
Rosuvastatin—Pain—Capecitabine—breast cancer	3.93e-05	0.000389	CcSEcCtD
Rosuvastatin—Constipation—Capecitabine—breast cancer	3.93e-05	0.000389	CcSEcCtD
Rosuvastatin—Feeling abnormal—Docetaxel—breast cancer	3.92e-05	0.000387	CcSEcCtD
Rosuvastatin—Nausea—Fluorouracil—breast cancer	3.91e-05	0.000387	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Docetaxel—breast cancer	3.89e-05	0.000384	CcSEcCtD
Rosuvastatin—Flatulence—Epirubicin—breast cancer	3.87e-05	0.000383	CcSEcCtD
Rosuvastatin—Diarrhoea—Paclitaxel—breast cancer	3.84e-05	0.000379	CcSEcCtD
Rosuvastatin—Feeling abnormal—Capecitabine—breast cancer	3.79e-05	0.000375	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Capecitabine—breast cancer	3.76e-05	0.000372	CcSEcCtD
Rosuvastatin—Abdominal pain—Docetaxel—breast cancer	3.76e-05	0.000371	CcSEcCtD
Rosuvastatin—Arrhythmia—Doxorubicin—breast cancer	3.73e-05	0.000369	CcSEcCtD
Rosuvastatin—Dizziness—Paclitaxel—breast cancer	3.71e-05	0.000367	CcSEcCtD
Rosuvastatin—Cough—Methotrexate—breast cancer	3.66e-05	0.000362	CcSEcCtD
Rosuvastatin—Mental disorder—Doxorubicin—breast cancer	3.66e-05	0.000362	CcSEcCtD
Rosuvastatin—Urticaria—Capecitabine—breast cancer	3.65e-05	0.000361	CcSEcCtD
Rosuvastatin—Abdominal pain—Capecitabine—breast cancer	3.64e-05	0.00036	CcSEcCtD
Rosuvastatin—Flatulence—Doxorubicin—breast cancer	3.58e-05	0.000354	CcSEcCtD
Rosuvastatin—Myalgia—Methotrexate—breast cancer	3.57e-05	0.000353	CcSEcCtD
Rosuvastatin—Arthralgia—Methotrexate—breast cancer	3.57e-05	0.000353	CcSEcCtD
Rosuvastatin—Rash—Paclitaxel—breast cancer	3.53e-05	0.000349	CcSEcCtD
Rosuvastatin—Dermatitis—Paclitaxel—breast cancer	3.53e-05	0.000349	CcSEcCtD
Rosuvastatin—Headache—Paclitaxel—breast cancer	3.51e-05	0.000347	CcSEcCtD
Rosuvastatin—Hypersensitivity—Docetaxel—breast cancer	3.5e-05	0.000346	CcSEcCtD
Rosuvastatin—Confusional state—Methotrexate—breast cancer	3.45e-05	0.000341	CcSEcCtD
Rosuvastatin—Cough—Epirubicin—breast cancer	3.43e-05	0.000339	CcSEcCtD
Rosuvastatin—Asthenia—Docetaxel—breast cancer	3.41e-05	0.000337	CcSEcCtD
Rosuvastatin—Infection—Methotrexate—breast cancer	3.4e-05	0.000336	CcSEcCtD
Rosuvastatin—Hypersensitivity—Capecitabine—breast cancer	3.39e-05	0.000335	CcSEcCtD
Rosuvastatin—Pruritus—Docetaxel—breast cancer	3.36e-05	0.000332	CcSEcCtD
Rosuvastatin—Nervous system disorder—Methotrexate—breast cancer	3.36e-05	0.000332	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Methotrexate—breast cancer	3.35e-05	0.000332	CcSEcCtD
Rosuvastatin—Myalgia—Epirubicin—breast cancer	3.34e-05	0.000331	CcSEcCtD
Rosuvastatin—Arthralgia—Epirubicin—breast cancer	3.34e-05	0.000331	CcSEcCtD
Rosuvastatin—Nausea—Paclitaxel—breast cancer	3.33e-05	0.000329	CcSEcCtD
Rosuvastatin—Asthenia—Capecitabine—breast cancer	3.3e-05	0.000326	CcSEcCtD
Rosuvastatin—Pruritus—Capecitabine—breast cancer	3.25e-05	0.000322	CcSEcCtD
Rosuvastatin—Diarrhoea—Docetaxel—breast cancer	3.25e-05	0.000321	CcSEcCtD
Rosuvastatin—Confusional state—Epirubicin—breast cancer	3.23e-05	0.000319	CcSEcCtD
Rosuvastatin—Infection—Epirubicin—breast cancer	3.18e-05	0.000315	CcSEcCtD
Rosuvastatin—Cough—Doxorubicin—breast cancer	3.17e-05	0.000313	CcSEcCtD
Rosuvastatin—Diarrhoea—Capecitabine—breast cancer	3.15e-05	0.000311	CcSEcCtD
Rosuvastatin—Nervous system disorder—Epirubicin—breast cancer	3.14e-05	0.000311	CcSEcCtD
Rosuvastatin—Dizziness—Docetaxel—breast cancer	3.14e-05	0.000311	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Epirubicin—breast cancer	3.14e-05	0.00031	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Methotrexate—breast cancer	3.12e-05	0.000308	CcSEcCtD
Rosuvastatin—Insomnia—Methotrexate—breast cancer	3.1e-05	0.000306	CcSEcCtD
Rosuvastatin—Arthralgia—Doxorubicin—breast cancer	3.09e-05	0.000306	CcSEcCtD
Rosuvastatin—Myalgia—Doxorubicin—breast cancer	3.09e-05	0.000306	CcSEcCtD
Rosuvastatin—Paraesthesia—Methotrexate—breast cancer	3.07e-05	0.000304	CcSEcCtD
Rosuvastatin—Dizziness—Capecitabine—breast cancer	3.04e-05	0.000301	CcSEcCtD
Rosuvastatin—Dyspepsia—Methotrexate—breast cancer	3.01e-05	0.000298	CcSEcCtD
Rosuvastatin—Rash—Docetaxel—breast cancer	3e-05	0.000296	CcSEcCtD
Rosuvastatin—Dermatitis—Docetaxel—breast cancer	2.99e-05	0.000296	CcSEcCtD
Rosuvastatin—Confusional state—Doxorubicin—breast cancer	2.99e-05	0.000296	CcSEcCtD
Rosuvastatin—Headache—Docetaxel—breast cancer	2.98e-05	0.000294	CcSEcCtD
Rosuvastatin—Infection—Doxorubicin—breast cancer	2.95e-05	0.000291	CcSEcCtD
Rosuvastatin—Pain—Methotrexate—breast cancer	2.93e-05	0.00029	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Epirubicin—breast cancer	2.92e-05	0.000289	CcSEcCtD
Rosuvastatin—Nervous system disorder—Doxorubicin—breast cancer	2.91e-05	0.000288	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Doxorubicin—breast cancer	2.9e-05	0.000287	CcSEcCtD
Rosuvastatin—Rash—Capecitabine—breast cancer	2.9e-05	0.000287	CcSEcCtD
Rosuvastatin—Insomnia—Epirubicin—breast cancer	2.9e-05	0.000287	CcSEcCtD
Rosuvastatin—Dermatitis—Capecitabine—breast cancer	2.9e-05	0.000287	CcSEcCtD
Rosuvastatin—Headache—Capecitabine—breast cancer	2.88e-05	0.000285	CcSEcCtD
Rosuvastatin—Paraesthesia—Epirubicin—breast cancer	2.88e-05	0.000285	CcSEcCtD
Rosuvastatin—Nausea—Docetaxel—breast cancer	2.82e-05	0.000279	CcSEcCtD
Rosuvastatin—Feeling abnormal—Methotrexate—breast cancer	2.82e-05	0.000279	CcSEcCtD
Rosuvastatin—Dyspepsia—Epirubicin—breast cancer	2.82e-05	0.000279	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Methotrexate—breast cancer	2.8e-05	0.000277	CcSEcCtD
Rosuvastatin—Constipation—Epirubicin—breast cancer	2.74e-05	0.000271	CcSEcCtD
Rosuvastatin—Pain—Epirubicin—breast cancer	2.74e-05	0.000271	CcSEcCtD
Rosuvastatin—Nausea—Capecitabine—breast cancer	2.73e-05	0.00027	CcSEcCtD
Rosuvastatin—Urticaria—Methotrexate—breast cancer	2.72e-05	0.000269	CcSEcCtD
Rosuvastatin—Abdominal pain—Methotrexate—breast cancer	2.71e-05	0.000268	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.7e-05	0.000267	CcSEcCtD
Rosuvastatin—Insomnia—Doxorubicin—breast cancer	2.68e-05	0.000265	CcSEcCtD
Rosuvastatin—Paraesthesia—Doxorubicin—breast cancer	2.66e-05	0.000263	CcSEcCtD
Rosuvastatin—Feeling abnormal—Epirubicin—breast cancer	2.64e-05	0.000261	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Epirubicin—breast cancer	2.62e-05	0.000259	CcSEcCtD
Rosuvastatin—Dyspepsia—Doxorubicin—breast cancer	2.61e-05	0.000258	CcSEcCtD
Rosuvastatin—Urticaria—Epirubicin—breast cancer	2.55e-05	0.000252	CcSEcCtD
Rosuvastatin—Pain—Doxorubicin—breast cancer	2.54e-05	0.000251	CcSEcCtD
Rosuvastatin—Constipation—Doxorubicin—breast cancer	2.54e-05	0.000251	CcSEcCtD
Rosuvastatin—Abdominal pain—Epirubicin—breast cancer	2.53e-05	0.00025	CcSEcCtD
Rosuvastatin—Hypersensitivity—Methotrexate—breast cancer	2.52e-05	0.000249	CcSEcCtD
Rosuvastatin—Asthenia—Methotrexate—breast cancer	2.46e-05	0.000243	CcSEcCtD
Rosuvastatin—Feeling abnormal—Doxorubicin—breast cancer	2.44e-05	0.000242	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Doxorubicin—breast cancer	2.42e-05	0.00024	CcSEcCtD
Rosuvastatin—Pruritus—Methotrexate—breast cancer	2.42e-05	0.00024	CcSEcCtD
Rosuvastatin—Hypersensitivity—Epirubicin—breast cancer	2.36e-05	0.000233	CcSEcCtD
Rosuvastatin—Urticaria—Doxorubicin—breast cancer	2.36e-05	0.000233	CcSEcCtD
Rosuvastatin—Abdominal pain—Doxorubicin—breast cancer	2.34e-05	0.000232	CcSEcCtD
Rosuvastatin—Diarrhoea—Methotrexate—breast cancer	2.34e-05	0.000232	CcSEcCtD
Rosuvastatin—Asthenia—Epirubicin—breast cancer	2.3e-05	0.000227	CcSEcCtD
Rosuvastatin—Pruritus—Epirubicin—breast cancer	2.27e-05	0.000224	CcSEcCtD
Rosuvastatin—Dizziness—Methotrexate—breast cancer	2.26e-05	0.000224	CcSEcCtD
Rosuvastatin—Diarrhoea—Epirubicin—breast cancer	2.19e-05	0.000217	CcSEcCtD
Rosuvastatin—Hypersensitivity—Doxorubicin—breast cancer	2.18e-05	0.000216	CcSEcCtD
Rosuvastatin—Rash—Methotrexate—breast cancer	2.16e-05	0.000213	CcSEcCtD
Rosuvastatin—Dermatitis—Methotrexate—breast cancer	2.16e-05	0.000213	CcSEcCtD
Rosuvastatin—Headache—Methotrexate—breast cancer	2.15e-05	0.000212	CcSEcCtD
Rosuvastatin—Asthenia—Doxorubicin—breast cancer	2.13e-05	0.00021	CcSEcCtD
Rosuvastatin—Dizziness—Epirubicin—breast cancer	2.12e-05	0.00021	CcSEcCtD
Rosuvastatin—Pruritus—Doxorubicin—breast cancer	2.1e-05	0.000207	CcSEcCtD
Rosuvastatin—Nausea—Methotrexate—breast cancer	2.03e-05	0.000201	CcSEcCtD
Rosuvastatin—Diarrhoea—Doxorubicin—breast cancer	2.03e-05	0.000201	CcSEcCtD
Rosuvastatin—Rash—Epirubicin—breast cancer	2.02e-05	0.0002	CcSEcCtD
Rosuvastatin—Dermatitis—Epirubicin—breast cancer	2.02e-05	0.0002	CcSEcCtD
Rosuvastatin—Headache—Epirubicin—breast cancer	2.01e-05	0.000199	CcSEcCtD
Rosuvastatin—Dizziness—Doxorubicin—breast cancer	1.96e-05	0.000194	CcSEcCtD
Rosuvastatin—Nausea—Epirubicin—breast cancer	1.9e-05	0.000188	CcSEcCtD
Rosuvastatin—Rash—Doxorubicin—breast cancer	1.87e-05	0.000185	CcSEcCtD
Rosuvastatin—Dermatitis—Doxorubicin—breast cancer	1.87e-05	0.000185	CcSEcCtD
Rosuvastatin—Headache—Doxorubicin—breast cancer	1.86e-05	0.000184	CcSEcCtD
Rosuvastatin—Nausea—Doxorubicin—breast cancer	1.76e-05	0.000174	CcSEcCtD
Rosuvastatin—CYP2C19—Metabolism—FASN—breast cancer	2.07e-06	2.61e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—BCHE—breast cancer	2.06e-06	2.6e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—HSP90AA1—breast cancer	2.06e-06	2.6e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP17A1—breast cancer	2.04e-06	2.58e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC5A5—breast cancer	2.04e-06	2.57e-05	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PTEN—breast cancer	2.03e-06	2.55e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ENO1—breast cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS1—breast cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CG—breast cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CD—breast cancer	2.02e-06	2.55e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.02e-06	2.54e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ABCB1—breast cancer	2.01e-06	2.53e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NCOA1—breast cancer	2.01e-06	2.53e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—ALB—breast cancer	1.99e-06	2.51e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.99e-06	2.51e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP2D6—breast cancer	1.98e-06	2.5e-05	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PIK3CA—breast cancer	1.98e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CYP19A1—breast cancer	1.98e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—STK11—breast cancer	1.98e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTA4—breast cancer	1.98e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CA9—breast cancer	1.98e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—TYMS—breast cancer	1.97e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CDKN1B—breast cancer	1.97e-06	2.49e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NQO1—breast cancer	1.97e-06	2.48e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—SLC2A1—breast cancer	1.97e-06	2.48e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CB—breast cancer	1.96e-06	2.47e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GSTM1—breast cancer	1.95e-06	2.46e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PLA2G4A—breast cancer	1.95e-06	2.46e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NCOR1—breast cancer	1.95e-06	2.46e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NCOA2—breast cancer	1.95e-06	2.45e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTGS2—breast cancer	1.94e-06	2.44e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.93e-06	2.43e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GPX2—breast cancer	1.93e-06	2.43e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTA2—breast cancer	1.93e-06	2.43e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.92e-06	2.42e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP3A4—breast cancer	1.92e-06	2.42e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.91e-06	2.41e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NOS3—breast cancer	1.91e-06	2.4e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GPX4—breast cancer	1.9e-06	2.4e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SULT1A1—breast cancer	1.9e-06	2.4e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—ALB—breast cancer	1.9e-06	2.39e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—SRC—breast cancer	1.89e-06	2.38e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—FASN—breast cancer	1.89e-06	2.38e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP1B1—breast cancer	1.89e-06	2.38e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—BCHE—breast cancer	1.88e-06	2.37e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—GPX1—breast cancer	1.87e-06	2.35e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CTNNB1—breast cancer	1.86e-06	2.35e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC5A5—breast cancer	1.86e-06	2.34e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—IDH1—breast cancer	1.86e-06	2.34e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTA1—breast cancer	1.86e-06	2.34e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.86e-06	2.34e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.85e-06	2.33e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CYP1A1—breast cancer	1.85e-06	2.33e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VEGFA—breast cancer	1.84e-06	2.32e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—COMT—breast cancer	1.84e-06	2.31e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NAT2—breast cancer	1.84e-06	2.31e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ERCC2—breast cancer	1.83e-06	2.31e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTP1—breast cancer	1.83e-06	2.3e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CDKN1A—breast cancer	1.82e-06	2.29e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PTEN—breast cancer	1.82e-06	2.29e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NOS3—breast cancer	1.81e-06	2.28e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—HMOX1—breast cancer	1.8e-06	2.27e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NCOA1—breast cancer	1.8e-06	2.27e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ITPR1—breast cancer	1.8e-06	2.27e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—SLC2A1—breast cancer	1.79e-06	2.26e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NQO1—breast cancer	1.79e-06	2.26e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CD—breast cancer	1.78e-06	2.24e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—STK11—breast cancer	1.77e-06	2.24e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP19A1—breast cancer	1.77e-06	2.24e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CB—breast cancer	1.76e-06	2.22e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.76e-06	2.21e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—ALB—breast cancer	1.75e-06	2.21e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP3A4—breast cancer	1.75e-06	2.2e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTGS2—breast cancer	1.74e-06	2.2e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.74e-06	2.19e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—MAPK3—breast cancer	1.74e-06	2.19e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ABCB1—breast cancer	1.73e-06	2.18e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—MTHFR—breast cancer	1.72e-06	2.17e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP1B1—breast cancer	1.72e-06	2.17e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—TYMS—breast cancer	1.7e-06	2.14e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PTEN—breast cancer	1.69e-06	2.13e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TGFB1—breast cancer	1.69e-06	2.13e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.69e-06	2.13e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—SRC—breast cancer	1.69e-06	2.12e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PLA2G4A—breast cancer	1.68e-06	2.12e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GSTM1—breast cancer	1.68e-06	2.12e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NCOR1—breast cancer	1.68e-06	2.12e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NOS3—breast cancer	1.68e-06	2.11e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.67e-06	2.11e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.67e-06	2.1e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTGS2—breast cancer	1.66e-06	2.09e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—COMT—breast cancer	1.65e-06	2.08e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTP1—breast cancer	1.64e-06	2.07e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NCOA1—breast cancer	1.64e-06	2.07e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—STAT3—breast cancer	1.63e-06	2.05e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—HMOX1—breast cancer	1.62e-06	2.04e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP19A1—breast cancer	1.62e-06	2.04e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—STK11—breast cancer	1.62e-06	2.04e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ITPR1—breast cancer	1.62e-06	2.04e-05	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—AKT1—breast cancer	1.61e-06	2.03e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—MED12—breast cancer	1.61e-06	2.03e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—DPYD—breast cancer	1.61e-06	2.03e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—GPX1—breast cancer	1.61e-06	2.03e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CYP1A1—breast cancer	1.59e-06	2.01e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CAV1—breast cancer	1.59e-06	2e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ALDOA—breast cancer	1.59e-06	2e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—ERCC2—breast cancer	1.58e-06	1.99e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—KRAS—breast cancer	1.56e-06	1.97e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ABCB1—breast cancer	1.55e-06	1.96e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MAPK3—breast cancer	1.55e-06	1.96e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CB—breast cancer	1.55e-06	1.95e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NCOA3—breast cancer	1.54e-06	1.94e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTGS2—breast cancer	1.54e-06	1.93e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC2A2—breast cancer	1.53e-06	1.93e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—TYMS—breast cancer	1.53e-06	1.92e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PTEN—breast cancer	1.52e-06	1.92e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.52e-06	1.91e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PIK3CA—breast cancer	1.52e-06	1.91e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—MYC—breast cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GSTM1—breast cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NCOR1—breast cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TGFB1—breast cancer	1.51e-06	1.9e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—COMT—breast cancer	1.5e-06	1.89e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—MTR—breast cancer	1.5e-06	1.89e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ABCG2—breast cancer	1.5e-06	1.89e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CPT1A—breast cancer	1.5e-06	1.89e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTP1—breast cancer	1.5e-06	1.89e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—MTHFR—breast cancer	1.49e-06	1.87e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—EGFR—breast cancer	1.48e-06	1.86e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—HMOX1—breast cancer	1.48e-06	1.86e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ITPR1—breast cancer	1.47e-06	1.86e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HPGDS—breast cancer	1.47e-06	1.85e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HBA1—breast cancer	1.46e-06	1.84e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CG—breast cancer	1.45e-06	1.83e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PTEN—breast cancer	1.45e-06	1.82e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—GPX1—breast cancer	1.44e-06	1.82e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—PIK3CA—breast cancer	1.44e-06	1.81e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP1A1—breast cancer	1.43e-06	1.8e-05	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PIK3CA—breast cancer	1.43e-06	1.8e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ACHE—breast cancer	1.42e-06	1.79e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTT1—breast cancer	1.42e-06	1.79e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ERCC2—breast cancer	1.42e-06	1.79e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ABCB1—breast cancer	1.42e-06	1.79e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—KRAS—breast cancer	1.4e-06	1.76e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—TYMS—breast cancer	1.39e-06	1.75e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—breast cancer	1.39e-06	1.75e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GSTM1—breast cancer	1.38e-06	1.73e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.38e-06	1.73e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NCOR1—breast cancer	1.38e-06	1.73e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CAV1—breast cancer	1.37e-06	1.73e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP17A1—breast cancer	1.35e-06	1.7e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PTEN—breast cancer	1.34e-06	1.69e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS1—breast cancer	1.33e-06	1.68e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ENO1—breast cancer	1.33e-06	1.68e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—MTHFR—breast cancer	1.33e-06	1.68e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—HRAS—breast cancer	1.33e-06	1.68e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—GPX1—breast cancer	1.32e-06	1.66e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.31e-06	1.65e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP2D6—breast cancer	1.31e-06	1.65e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP1A1—breast cancer	1.3e-06	1.64e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ERCC2—breast cancer	1.29e-06	1.63e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NCOA2—breast cancer	1.28e-06	1.62e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—PIK3CA—breast cancer	1.28e-06	1.61e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CD—breast cancer	1.27e-06	1.6e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—ALB—breast cancer	1.26e-06	1.58e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CG—breast cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—FASN—breast cancer	1.25e-06	1.57e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—BCHE—breast cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—AKT1—breast cancer	1.24e-06	1.56e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CAV1—breast cancer	1.23e-06	1.55e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC5A5—breast cancer	1.23e-06	1.54e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—MTHFR—breast cancer	1.22e-06	1.53e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NOS3—breast cancer	1.2e-06	1.52e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PIK3CA—breast cancer	1.19e-06	1.5e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HRAS—breast cancer	1.19e-06	1.49e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NQO1—breast cancer	1.18e-06	1.49e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—SLC2A1—breast cancer	1.18e-06	1.49e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.17e-06	1.48e-05	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—AKT1—breast cancer	1.17e-06	1.48e-05	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—AKT1—breast cancer	1.17e-06	1.47e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—IL6—breast cancer	1.14e-06	1.43e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP1B1—breast cancer	1.13e-06	1.43e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CAV1—breast cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CG—breast cancer	1.12e-06	1.41e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.11e-06	1.4e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CB—breast cancer	1.11e-06	1.4e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTGS2—breast cancer	1.1e-06	1.39e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CD—breast cancer	1.1e-06	1.38e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NCOA1—breast cancer	1.08e-06	1.36e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PIK3CA—breast cancer	1.07e-06	1.35e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.07e-06	1.35e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—STK11—breast cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP19A1—breast cancer	1.07e-06	1.34e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—AKT1—breast cancer	1.05e-06	1.32e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NOS3—breast cancer	1.04e-06	1.3e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CG—breast cancer	1.02e-06	1.29e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.02e-06	1.29e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—COMT—breast cancer	9.92e-07	1.25e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTP1—breast cancer	9.87e-07	1.24e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CD—breast cancer	9.85e-07	1.24e-05	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—AKT1—breast cancer	9.75e-07	1.23e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—HMOX1—breast cancer	9.74e-07	1.23e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—ALB—breast cancer	9.72e-07	1.22e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ITPR1—breast cancer	9.71e-07	1.22e-05	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PTEN—breast cancer	9.59e-07	1.21e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CB—breast cancer	9.56e-07	1.2e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTGS2—breast cancer	9.47e-07	1.19e-05	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PIK3CA—breast cancer	9.45e-07	1.19e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ABCB1—breast cancer	9.34e-07	1.18e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NOS3—breast cancer	9.3e-07	1.17e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—TYMS—breast cancer	9.18e-07	1.16e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NCOR1—breast cancer	9.07e-07	1.14e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GSTM1—breast cancer	9.07e-07	1.14e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PLA2G4A—breast cancer	9.07e-07	1.14e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CD—breast cancer	8.98e-07	1.13e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—ALB—breast cancer	8.86e-07	1.12e-05	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—AKT1—breast cancer	8.77e-07	1.1e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—GPX1—breast cancer	8.69e-07	1.09e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP1A1—breast cancer	8.6e-07	1.08e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CB—breast cancer	8.58e-07	1.08e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ERCC2—breast cancer	8.53e-07	1.07e-05	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTGS2—breast cancer	8.5e-07	1.07e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NOS3—breast cancer	8.48e-07	1.07e-05	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—AKT1—breast cancer	8.33e-07	1.05e-05	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PTEN—breast cancer	8.26e-07	1.04e-05	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—MTHFR—breast cancer	8.02e-07	1.01e-05	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CB—breast cancer	7.83e-07	9.86e-06	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTGS2—breast cancer	7.75e-07	9.77e-06	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—AKT1—breast cancer	7.72e-07	9.72e-06	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PTEN—breast cancer	7.42e-07	9.34e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CAV1—breast cancer	7.4e-07	9.32e-06	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PIK3CA—breast cancer	6.77e-07	8.53e-06	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PTEN—breast cancer	6.76e-07	8.52e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CG—breast cancer	6.74e-07	8.49e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CD—breast cancer	5.92e-07	7.46e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—ALB—breast cancer	5.85e-07	7.36e-06	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PIK3CA—breast cancer	5.83e-07	7.34e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NOS3—breast cancer	5.59e-07	7.04e-06	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—AKT1—breast cancer	5.53e-07	6.97e-06	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PIK3CA—breast cancer	5.23e-07	6.59e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CB—breast cancer	5.16e-07	6.5e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTGS2—breast cancer	5.11e-07	6.44e-06	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PIK3CA—breast cancer	4.77e-07	6.01e-06	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—AKT1—breast cancer	4.76e-07	6e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PTEN—breast cancer	4.46e-07	5.62e-06	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—AKT1—breast cancer	4.27e-07	5.39e-06	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—AKT1—breast cancer	3.9e-07	4.91e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PIK3CA—breast cancer	3.15e-07	3.96e-06	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—AKT1—breast cancer	2.57e-07	3.24e-06	CbGpPWpGaD
